HCA Healthcare (NYSE:HCA) had its target price boosted by investment analysts at Deutsche Bank Aktiengesellschaft from $180.00 to $210.00 in a report released on Tuesday, The Fly reports. The brokerage currently has a “buy” rating on the stock. Deutsche Bank Aktiengesellschaft’s price objective points to a potential upside of 9.98% from the stock’s previous close.
Several other brokerages also recently commented on HCA. Raymond James upped their price target on shares of HCA Healthcare from $150.00 to $190.00 and gave the company an “outperform” rating in a research report on Wednesday, February 3rd. JPMorgan Chase & Co. upgraded shares of HCA Healthcare from a “neutral” rating to an “overweight” rating and increased their price target for the stock from $143.00 to $194.00 in a research note on Monday, December 14th. Mizuho raised their target price on shares of HCA Healthcare from $195.00 to $205.00 and gave the company a “buy” rating in a research note on Friday, April 9th. Credit Suisse Group raised their target price on shares of HCA Healthcare from $197.00 to $201.00 and gave the company an “outperform” rating in a research note on Wednesday, February 3rd. Finally, Truist raised their price target on shares of HCA Healthcare from $165.00 to $190.00 in a research report on Tuesday, January 5th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and fifteen have issued a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $177.28.
Shares of HCA Healthcare stock opened at $190.95 on Tuesday. The firm has a market cap of $64.34 billion, a PE ratio of 19.31, a price-to-earnings-growth ratio of 1.28 and a beta of 1.58. The firm’s 50-day simple moving average is $185.10 and its 200-day simple moving average is $161.99. The company has a debt-to-equity ratio of 23.70, a quick ratio of 1.00 and a current ratio of 1.13. HCA Healthcare has a 1 year low of $91.21 and a 1 year high of $194.01.
In related news, Director Wayne Joseph Riley sold 1,650 shares of the business’s stock in a transaction dated Wednesday, February 3rd. The stock was sold at an average price of $166.19, for a total value of $274,213.50. Following the sale, the director now directly owns 14,119 shares in the company, valued at approximately $2,346,436.61. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Michael S. Cuffe sold 7,574 shares of the business’s stock in a transaction dated Wednesday, February 3rd. The shares were sold at an average price of $171.17, for a total value of $1,296,441.58. The disclosure for this sale can be found here. In the last three months, insiders sold 109,810 shares of company stock valued at $19,453,297. 1.80% of the stock is currently owned by insiders.
Several hedge funds and other institutional investors have recently modified their holdings of HCA. Profit Investment Management LLC bought a new stake in HCA Healthcare in the first quarter valued at approximately $217,000. CVA Family Office LLC raised its holdings in shares of HCA Healthcare by 98.0% during the first quarter. CVA Family Office LLC now owns 485 shares of the company’s stock valued at $91,000 after acquiring an additional 240 shares in the last quarter. FDx Advisors Inc. grew its stake in HCA Healthcare by 15.6% in the first quarter. FDx Advisors Inc. now owns 3,111 shares of the company’s stock worth $586,000 after purchasing an additional 420 shares during the period. Redpoint Investment Management Pty Ltd grew its stake in HCA Healthcare by 2.0% in the first quarter. Redpoint Investment Management Pty Ltd now owns 7,925 shares of the company’s stock worth $1,493,000 after purchasing an additional 155 shares during the period. Finally, Royal London Asset Management Ltd. grew its stake in HCA Healthcare by 4.4% in the first quarter. Royal London Asset Management Ltd. now owns 673,255 shares of the company’s stock worth $126,801,000 after purchasing an additional 28,223 shares during the period. 68.69% of the stock is owned by institutional investors.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, operates as a health care services company in the United States. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Featured Article: What does RSI mean?
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.